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Several host translation elongation factors have been suggested to play essential roles in the replication and translation of viral RNAs in plants,
animals and bacteria. Here, we show the interaction between eukaryotic translation elongation factor 1A (eEF1A) and Tobacco mosaic virus
(TMV) RNA-dependent RNA polymerase (RdRp) in vivo by immunoprecipitation. The tobacco eEF1A interacted not only with 3V-untranslated
region (3V-UTR) of TMV RNA but also directly with RdRp without mediation by the 3V-UTR. The methyltransferase domain of TMV RdRp was
indicated to be responsible for the interaction with eEF1A in vitro and in yeast. These results suggest that eEF1A is a component of the virus
replication complex of TMV.
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A lot of efforts have been made to elucidate the host
factors involved in each infection step of RNA viruses, and
such studies have revealed that there should be a variety of
host–virus interactions (Ahlquist et al., 2003; Kushner et al.,
2003; Lai, 1998; Panavas et al., 2005; Whitham and Wang,
2004). Host translation elongation factors (EFs) have been
assumed to participate in the multiplication of some RNA
viruses infecting animals, plants and bacteria (Lai, 1998). Two
types of reports have described the relationships between EF
and viral multiplication so far. The one case is the interaction
between EF and viral RNA-dependent RNA polymerase
(RdRp). Bacteriophage Qh replicase complex contains the
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Japan.(Blumenthal et al., 1972). They interacted with each other
solidly and also with viral RdRp and were indispensable
components for both positive- and negative-strand RNA
syntheses (Blumenthal and Carmichael, 1979). In the in vitro
replication system of an animal virus, Vesicular stomatitis
virus (VSV), eukaryotic translation elongation factor 1A
(eEF1A) and eEF1B subunits interacted with VSV RdRp
and were essential components for viral replication (Das et al.,
1998). The interactions of EF to viral RdRp were also
reported in some other animal viruses including Bovine viral
diarrhea virus (BVDV) and poliovirus (Johnson et al., 2001;
Harris et al., 1994). In these reports, EFs were suggested to be
essential for viral RNA replication.
The other case is the interaction between eEF1A and viral
genomic RNA of plant viruses including Brome mosaic virus
(BMV) (Bastin and Hall, 1976), Turnip yellow mosaic virus
(TYMV) (Joshi et al., 1986) and Tobacco mosaic virus (TMV)
(Zeenko et al., 2002) and animal viruses including West Nile
virus (Blackwell and Brinton, 1997) and Dengue 4 virus (De
Nova-Ocampo et al., 2002). The RdRp isolated from TYMV-
infected plants did not contain eEF1A (Joshi et al., 1986). The
interaction between eEF1A and 3V-untranslated region (3V-UTR)
of TYMV genomic RNA was suggested to enhance the6) 100 – 108
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suppress the minus-strand RNA synthesis (Matsuda et al., 2004).
Thus, EFs are likely candidates for the components of the viral
RNA replication or translation, but it is still not clear whether the
effect of EF on viral replication or translation is universally
similar among RNA viruses or specific for each virus.
TMV is the first virus to be discovered and has been studied
as a model of RNA virus for long years. TMV, belonging to the
genus Tobamovirus, has a 5V-capped single-stranded RNA
genome, which is approximately 6.4 kb long and has a tRNA-
like structure (TLS) in its 3V-terminus. The genome has four
open reading frames encoding 126 kDa (126K) and 183 kDa
(183K) components of RdRp, 30 kDa movement protein (MP)
and 17.5 kDa coat protein (CP). 126K and 183K are N-
terminally overlapping, and 183K is translated by the read-
through of the amber termination codon of 126K. 126K
contains two conserved, methyltransferase (M) and helicase
(H), domains. The region between the M and H domain is
designated as the internal (I) region. 183K contains another
conserved polymerase (P) domain in addition to the M, H
domain and the I region of 126K. 126K and 183K are TMV
RNA-specific RdRp, which are associated with intracellular
membrane structures (Hagiwara et al., 2003; Mas and Beachy,
1999; Osman and Buck, 1996). In vivo accumulation of 126K
is approximately tenfold higher than that of 183K (Ishikawa et
al., 1986; Lewandowski and Dawson, 2000), and the active
state of TMV RdRp contains the heterodimer of 126K and
183K (Watanabe et al., 1999).
Several host factors have been identified to be essential for
the RNA replication of tobamoviruses. Genetic studies using
Arabidopsis thaliana –tobamovirus infection system revealed
that transmembrane proteins TOM1 and TOM2A function as
anchors to recruit viral RdRp to cellular membranes, where viral
RNA replication occurs (Tsujimoto et al., 2003; Yamanaka et al.,
2000). Biochemical studies indicated that the active and
solubilized viral RdRp of Tomato mosaic virus (ToMV), purified
from virus-infected tomato leaves, contained GCD10-like
protein (a subunit of host translation initiation factor eIF3) and
that the RdRp activity was immunodepleted by the addition of
anti-GCD10 antibody (Osman and Buck, 1997). Recently, it was
reported that eEF1A from wheat germ and Nicotiana benthami-
ana interacted with the pseudoknot (PK) structure upstream of
TLS in the 3V-UTR of TMV RNA genome (Zeenko et al., 2002).
In this study, we showed that eEF1A interacts also with TMV
RdRp components 126K and 183K in vivo without mediation by
the 3V-UTR. The methyltransferase domain of TMV RdRp was
shown to be responsible for this interaction. Compared to the
previous reports on the roles of EFs in the multiplications of
other genera of RNAviruses, the possible functions of eEF1A in
TMV multiplication are discussed.
Results
Cloning and validation of tobacco eEF1A cDNA
We designed 5V- and 3V-terminal primers based on a
previously reported eEF1A cDNA clone from Nicotianatabacum cv. BY-2 cell (GenBank accession no. D63396) and
amplified the eEF1A cDNA from total RNA of N. tabacum cv.
Xanthi by RT-PCR. The sequence of the isolated eEF1A cDNA
was 1344 nt long and encoded a protein composed of 447
amino acids. Although three nucleotides were substituted
compared to the sequence of D63396, the amino acid sequence
was identical. Sequence homology between this tobacco
eEF1A protein and a wheat eEF1A (Swiss Prot. accession
no. Q03033, EMBL accession no. M90077) which had been
previously revealed to interact with the 3V-UTR of TMV
genomic RNA (Zeenko et al., 2002) was 94.8% at amino acid
level.
To investigate whether this tobacco eEF1A has the ability to
interact with the 3V-UTR of TMV genomic RNA similarly to
the report by Zeenko et al. (2002), we performed GST pull-
down assay for RNA. The GST-eEF1A fusion protein prepared
in Escherichia coli was immobilized to glutathione–agarose
beads, incubated with TMV RNA fragments and washed. The
RNA bound to GST-eEF1A was detected by silver staining.
When GST-eEF1A was incubated with the 3V-UTR fragment
(nucleotide position 6147 to 6394) of TMV genomic RNA, the
RNA fragment was pulled down together with GST-eEF1A
(Fig. 1A, lane 6). However, the 5V-UTR fragment (nucleotide
position 1 to 149) and MP RNA fragment (nucleotide position
5439 to 5708) of TMV genomic RNA were not pulled down
together with GST-eEF1A (Fig. 1A, lanes 7 and 8). When each
RNA fragment was incubated with GST, none of RNA
fragments was pulled down together with GST (Fig. 1A, lanes
10–12). We also confirmed the interaction of eEF1A and 3V-
UTR fragment of TMV RNA by the gel-mobility shift assay.
Similarly to the previous observation (Zeenko et al., 2002),
when the 3V-UTR fragment was incubated with GST-eEF1A, a
distinct RNA–protein complex showing slower electrophoretic
mobility was formed, although no such complex was detected
when the 3V-UTR fragment was incubated with GST (data not
shown). These results confirmed that the tobacco eEF1A
encoded within the present cDNA clone specifically interacts
with the 3V-UTR of TMV genomic RNA.
TMV RdRp activity has been found in the membrane-
associated protein fraction from TMV-infected tissues (Osman
and Buck, 1996; Watanabe et al., 1999). Therefore, we next
examined whether eEF1A is included in the membrane-
associated protein fraction. The extracts from TMV-infected
tobacco tissues were fractionated to generate the membrane-
associated P30 and the soluble S30 fractions by differential
centrifugation and solubilization by sodium taurodeoxycholate
(TDC). The immunoblot analysis of TMV RdRp using
antibody against the H domain (anti-H antibody) showed that
similar amount of 126K was included in both S30 and P30
fractions, but the amount of 183K was lower in the S30 than in
the P30 (Fig. 1B). The immunoblot analysis of each fraction
using anti-eEF1A antibody was examined to detect eEF1A.
Approximately, 50 kDa bands corresponding to the size of
eEF1A predicted by its amino acid sequence were found in
both S30 and P30 fractions (Fig. 1C). These results indicated
that eEF1A is included in both the soluble and membrane-
associated fraction in TMV-infected tissues. In the case of
Fig. 2. Co-immunoprecipitation of eEF1A and TMV RdRp. Two hundred
micrograms of proteins from P30 fraction were incubated with BSA, protein A
beads and indicated antibodies. Proteins immunoprecipitated with beads were
separated by SDS-7.5%PAGE and followed by zinc staining (A), immunoblot
analysis with anti-H domain (B, bottom panel) or anti-BSA (C, bottom panel)
antibody. Two percent each of the input protein–antibody mixture before
precipitation was analyzed by immunoblot analysis with anti-H domain (B, top
panel) or anti-BSA (C, top panel) antibody. The positions of 126K, 183K and
BSA are indicated by arrows.
Fig. 1. (A) GST pull-down assay for TMV RNA fragments. Indicated RNA
fragment was incubated with GST-eEF1A (lanes 5–8) or GST (lanes 9–12)
and pulled down by glutathione beads. The RNA fragments alone (lanes 1–4)
or RNA–protein complex associated with beads (lanes 5–12) were separated
by SDS-10%PAGE and detected by silver staining, which stains both RNA and
protein. Transcript from pBluescript was used as a negative control (lanes 1, 5
and 9). The positions of MP RNA, 3V-UTR, 5V-UTR, GST-eEF1A and GST
were indicated by arrows. (B and C) Subcellular distribution of tobacco eEF1A
and TMV RdRp. Ten micrograms each of soluble proteins from S30 fraction,
membrane-associated proteins from P30 fraction and TMV particles were
separated by SDS-10%PAGE and transferred to PVDF membranes. The
membranes were detected by anti-H domain (B) and anti-eEF1A domain (C)
antibodies. The positions of eEF1A, 126K and 183K are indicated by arrows.
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replicase are included in the viral particle (Cimarelli and
Luban, 1999). Therefore, the existence of eEF1A or TMV
RdRp in the TMV particles was examined using immunoblot
analyses, although TMV particles were known to contain its
genomic RNA and CP. It was confirmed that neither eEF1A
nor TMV RdRp exists in the viral particles (Figs. 1B and C).
Co-immunoprecipitation of eEF1A and TMV RdRp
In several RNA viruses infecting animals and bacteria, host
EFs were indicated to interact directly with viral RdRps (Lai,
1998). But, there have been no report of the direct interaction
between eEF1A and plant viral RdRp, although the interaction
between eEF1A and 3V-UTR of viral RNA was reported for
BMV, TYMV and TMV (Bastin and Hall, 1976; Joshi et al.,
1986; Zeenko et al., 2002, this study). Therefore, we surveyed
the interaction of eEF1A and TMV RdRp in vivo. We
performed the immunoprecipitation of P30 fraction using
anti-M, -P or -eEF1A rabbit polyclonal antibody. As a negative
control, bovine serum albumin (BSA) was added to P30fractions prior to the immunoprecipitation. The precipitated
proteins were analyzed by zinc staining (Fernandez-Patron et
al., 1995) and immunoblotting assays using anti-H or anti-BSA
antibody. 126K and 183K were observed in the immunopre-
cipitates by anti-M and anti-P antibody (Figs. 2A and B). The
amount of 126K exceeded that of 183K in the immunoprecip-
itate by anti-M antibody, while the amount of 126K was nearly
equal to that of 183K in the immunoprecipitate by anti-P
antibody, as previously demonstrated (Watanabe et al., 1999).
126K and 183K were also detected in the precipitate by anti-
eEF1A antibody (Figs. 2A and B), revealing the co-immuno-
precipitation of eEF1A and TMV RdRp components. In the
precipitate by anti-eEF1A antibody, the amount of 183K was
much lower than 126K, similarly to the precipitate by anti-M
antibody. Neither 126K nor 183K was detected in the
precipitates by pre-immune antibody and anti-BSA antibody
(Figs. 2A and B). The immunoblot assay using anti-BSA
antibody showed that BSA was not co-immunoprecipitated by
anti-M, -P, -eEF1A or pre-immune antibody but only by anti-
BSA antibody (Fig. 2C). These results strongly suggested that
eEF1A specifically interacted with 126K and 183K in vivo.
The co-immunoprecipitation of eEF1A and TMV RdRp
components was also observed using S30 fraction (data not
shown).
Fig. 4. GST pull-down assay to detect the interaction between each domain of
TMV RdRp and eEF1A. One milligram of proteins from S30 fractions was
incubated with GST or respective GST-fused domain proteins along with BSA
and pulled down by glutathione beads. Proteins pulled down with beads were
immunodetected by anti-GST (A), anti-eEF1A (B, bottom panel) or anti-BSA
(C, bottom panel) antibody. One percent each of the input protein mixture
before pull-down was analyzed by immunoblot analysis with anti-eEF1A (B,
top panel) or anti-BSA (C, top panel) antibody. The positions of eEF1A (B) and
BSA (C) are indicated by arrows.
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RdRp
The 3V-UTR of TMV genomic RNAwas reported to interact
with TMV RdRp (Osman and Buck, 2003) and also with
eEF1A (Zeenko et al., 2002). Therefore, we supposed a
possibility that eEF1A does not interact with TMV RdRp
directly and that the 3V-UTR of TMV RNA might intermediate
between eEF1A and TMV RdRp. To examine this possibility,
P30 fractions were incubated with different concentrations of
RNase A to digest TMV genomic RNA prior to the same
immunoprecipitation assays using anti-eEF1A antibody as
above. The amount of TMV genomic RNA in each fraction
was checked by RT-PCR using primers for amplifying the 3V-
UTR. The rise of RNase A concentrations caused the gradual
decrease of TMV genomic RNA (Fig. 3, top panel). However,
the amounts of 126K and 183K co-immunoprecipitated with
anti-eEF1A antibody were the same in every sample (Fig. 3,
middle and bottom panel). These results suggested that the
interaction of eEF1A and TMV RdRp was direct but not
mediated by the 3V-UTR of TMV genomic RNA.
Domain of TMV RdRp responsible for the interaction with
eEF1A
To investigate the domain (or region) of TMV RdRp
responsible for the interaction with eEF1A, GST pull-down
assay was performed. The fusion proteins between GST and
each domain (region) of TMV RdRp prepared in the E.
coli were used as probes and incubated with the S30
fraction of TMV-infected tissues in which BSA was added.
The GST-fused proteins were pulled down using glutathione
beads, and the precipitates were assayed by immunoblotting
using anti-GST, anti-eEF1A or anti-BSA antibody. Immu-
noblotting using anti-GST antibody confirmed that definite
amount of GST-fused proteins remained after over night
incubation without degradation (Fig. 4A). eEF1A wasFig. 3. Effect of RNase A on co-immunoprecipitation of eEF1A and TMV
RdRp. Two hundred micrograms of proteins from P30 fraction were incubated
with elevated concentrations of RNase A indicated. Samples were analyzed by
RT-PCR using primers designed to amplify a cDNA fragment corresponding to
the 3V-UTR of TMV genomic RNA (top panel). Samples were also
immunoprecipitated using anti-eEF1A antibody followed by immunoblot
analysis with anti-H domain (middle panel) or anti-P domain (bottom panel)
antibody. The positions of cDNA corresponding to the 3V-UTR of TMV
genomic RNA, 126K and 183K are indicated by arrows.specifically detected in the pulled down precipitate using
GST-M probe (Fig. 4B), whereas no BSA band was
detected in every pulled down precipitate (Fig. 4C). These
results suggested that eEF1A interacts with the M domain
of TMV RdRp. When P30 fraction was used in these
assays, no interaction signals between GST-fused probe
proteins and eEF1A were detected (data not shown). This
may be caused by the lower undetectable concentration of
eEF1A in the precipitates using P30 fraction since the total
protein concentration of this fraction was much lower than
that of S30 fraction.
To confirm these results obtained in the GST pull-down
assay, we performed the yeast two-hybrid assay. eEF1A fused
with Gal4 activation domain (AD) and each domain (M, I, H
and P) of TMV RdRp fused with Gal4 binding domain (BD)
were expressed together in yeast, and the growth of each
transformed yeast was assayed on the selection medium
lacking leucine, tryptophan, adenine and histidine. As shown
in Fig. 5, all the yeast harboring a plasmid expressing AD-
eEF1A together with a plasmid expressing BD-I, -H or -P did
not show any growth on the selection medium compared
with the positive control yeast harboring AD-ADC (tobacco
arginine decarboxylase fused with AD) together with BD-H
(Shimizu et al., 2004). However, only the yeast harboring
plasmids expressing AD-eEF1A and BD-M showed a faint
but distinguishable growth, which was reproducible in
triplicate experiments. These results supported the observa-
Fig. 5. Yeast two-hybrid assay. pAD or pAD-eEF1A was transformed together
with pBD, pBD-M, pBD-I, pBD-H or pBD-P into yeast strain AH109. The
transformed yeasts were diluted to 0.4, 0.04 and 0.004 absorbance at 600 nm
and spotted onto selection medium lacking leucine, tryptophan, adenine and
histidine (-LWAH). As a positive control, the growth of yeast harboring pAD-
ADC together with pBD-H on -LWAH medium was indicated at the bottom
panel.
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RdRp.
Discussion
The interaction between eEF1A and TMV RdRp
In this study, we revealed that eEF1A interacted with TMV
RdRp components, 126K and 183K. This is the first report on
the interaction between eEF1A and the RdRp of plant RNA
virus. Moreover, this is the first case that eEF1A interacts with
both the viral RdRp and viral genomic RNA. In the previous
study, we showed the co-immunoprecipitation of 126K and
183K by anti-P antibody in vivo and suggested that TMV
RdRp complex contains a heterodimer of 126K and 183K
(Watanabe et al., 1999). Similarly, we showed the co-
immunoprecipitation of 126K, 183K and eEF1A in this study.
The amount of 126K exceeded that of 183K in the
immunoprecipitate by anti-eEF1A, which is similarly observed
in the immunoprecipitate by anti-M antibody. As in vivo
accumulation of 126K is approximately tenfold higher than
that of 183K (Ishikawa et al., 1986; Lewandowski and
Dawson, 2000), this result indicated that eEF1A interacted
with the common domain of 126K and 183K. Actually, the M
domain was demonstrated to be responsible for this interaction.
We also showed that eEF1A is abundantly included in the
membrane-associated protein fraction where TMV RdRp
activity has been found (Osman and Buck, 1996; Watanabe
et al., 1999). The interaction between eEF1A and 126K or
183K was independent of viral RNA, indicating the directinteraction of them. Moreover, the zinc staining of the
immunoprecipitated proteins showed that only 126K was
detected to form a specific band in the immunoprecipitate by
anti-eEF1A antibody, indicating that TMV RdRp is a major
interactor of eEF1A in TMV-infected tissues. These results
suggest that eEF1A is included in the virus replication complex
(VRC; Asurmendi et al., 2004).
Osman and Buck (1997) showed that the RdRp complex of
ToMV purified from infected tomato leaves contained three
host factors, 56 kDa, 54 kDa and 50 kDa protein and that the
56 kDa protein is a subunit of eIF3, but details of the 54 kDa
and 50 kDa protein were not determined. Considering that the
molecular weight of the eEF1A used in this study is
approximately 50 kDa and that this value appears to be almost
universal among the other eEF1A proteins, it is possible that
either the 54 kDa or 50 kDa protein found in ToMV RdRp
complex is tomato eEF1A.
In this study, we showed that tobacco eEF1A interacted
with the 3V-UTR of TMV genomic RNA, which is similar to
the previous study that eEF1A of wheat and N. benthamiana
interacted with the 3V-UTR of TMV genomic RNA (Zeenko et
al., 2002). Therefore, the amino acid sequences of eEF1A
may be highly conserved among tobacco, N. benthamiana
and wheat. There are four copies of A. thaliana eEF1A
cDNA in the database, and Nicotiana plants also contain
several eEF1A copies (unpublished data). But since the amino
acid sequence of eEF1A may be highly conserved, it is
expected that eEF1A proteins encoded by each cDNA copy
show similar properties.
The RdRp activity of TMV or ToMV is involved in the
membrane-associated protein fraction of virus-infected tissues
(Hagiwara et al., 2003; Osman and Buck, 1996; Watanabe et
al., 1999). But, the distribution of 126K and 183K in soluble or
membrane-associated protein fractions was not clear. 183K
was detected in the P30 membrane-associated fraction more
than in the S30 soluble fraction, supporting that TMV RdRp
activities were membrane-associated. Therefore, the abundant
existence of eEF1A in P30 fraction support that eEF1A is
included in VRC. But, eEF1A and 126K were co-immunopre-
cipitated also in the S30 soluble fraction (data not shown). It
remains to be determined whether the complex of eEF1A and
126K in the soluble fraction has unknown functions. The
function of the abundant 126K in the soluble fraction is also to
be determined.
Role of eEF1A in the multiplication of TMV
It is unclear at present what role eEF1A plays in TMV
infection by the association with TMV RdRp. There have
been a number of reports about the relationships between EFs
and viral RNA replication. The functions of EFs on the viral
RNA replication have been suggested in each one of animal
viruses, plant viruses and bacteriophages. In the case of Qh
phage, where EFs interact with the RdRp, EFs are the
components included in virus replication complex and the
indispensable factor of viral RNA replication (Blumenthal and
Carmichael, 1979). EFs are also associated with VSV RdRp
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eEF1A is included in the viral multiprotein complex, which
transcribes capped mRNAs from viral negative-strand RNA,
however, is not included in the complex, which replicates
non-capped viral RNAs (Qanungo et al., 2004). In TYMV,
however, eEF1A interacted with the 3V-terminal tRNA-like
structure (TLS) of TYMV genomic RNA and inhibited the
minus strand synthesis by TYMV RdRp in vitro (Matsuda et
al., 2004). Since TLS is the translational enhancer of TYMV-
encoded proteins (Matsuda and Dreher, 2004), it was
suggested that the association of eEF1A with TLS inhibits
the access of TYMV RdRp to TLS and, therefore, represses
the minus strand synthesis. Although eEF1A inhibits the
replication of TYMV RNA, eEF1A totally supports the
accumulation of TYMV by functioning as a switch between
the replication and the translation of viral genomic RNA.
Thus, RNA viruses seem to utilize eEF1A in various ways to
support their multiplication.
There are two differences in the property of eEF1A on the
RNA replication between TMVand TYMV. One is that eEF1A
is not included in the TYMV RdRp complex (Joshi et al.,
1986), indicating that TYMV RdRp does not interact with
eEF1A. The other is that, while eEF1A interacts with the TLS
of TYMV genomic RNA (Matsuda et al., 2004), eEF1A
interacts with the pseudoknot (PK) structure upstream of TLS
in the 3V-UTR of TMV genomic RNA (Zeenko et al., 2002).
Since TMV RdRp interacts with TLS (Osman and Buck,
2003), it is possible that eEF1A and TMV RdRp do not
compete each other for interacting with the 3V-UTR of TMV
genomic RNA. Since PK is essential for the negative-strand
synthesis of TMV genomic RNA (Chandrika et al., 2000;
Osman et al., 2000; Takamatsu et al., 1990), the interaction
between eEF1A and PK may promote the TMV RNA
replication. The interaction of eEF1A and PK may also
promote the translation of TMV RNA because PK has been
recognized as a translational enhancer of TMV RNA (Gallie
and Walbot, 1990). Therefore, it is possible that the role of
eEF1A in TMV multiplication may be different from that in
TYMV multiplication.
The M domain (amino acid position 1 to 306) of TMV
RdRp, which is responsible for the interaction with eEF1A, is
important for TMV RNA replication. Amino acid substitution
in the N-terminal nuclear localizing signal (amino acid
position 44 and 45) as well as in the conserved motif (amino
acid position 81) disrupted the virus accumulation (dos Reis
Figueira et al., 2002; Merits et al., 1999). When deficient
126Ks, which were mutated in the M domain, were expressed
from defective RNAs (dRNAs) along with helper virus that
produced only 183K, dRNAs did not replicate, indicating that
the M domain is essential for the replication of TMV dRNAs
(Lewandowski and Dawson, 2000).
While eEF1A interacts with the M domain of TMV RdRp,
TMV RdRp interacts with TLS via the downstream region
(amino acid position 314 to 423) of the M domain (Osman
and Buck, 2003). Therefore, eEF1A and the 3V-UTR of TMV
genomic RNA do not compete with each other for interaction
with TMV RdRp. Active TMV VRC contains a heterodimerof 126K and 183K which is formed by the interaction
between the H domain and the IRnHEL (I region and N-
terminus of helicase domain) region including the C-terminal
half of the I region and the N-terminal portion of the H
domain (Goregaoker et al., 2002; Watanabe et al., 1999).
Therefore, eEF1A does not seem to inhibit this heterodimer
formation, although the tertiary structures of eEF1A molecule
might affect it. It was also suggested that 126K first binds to
3V-UTR of TMV genomic RNA and then followed by binding
of 183K to this complex (Lewandowski and Dawson, 2000;
Osman and Buck, 2003). Therefore, we suggest a following
hypothetical model of the function of eEF1A in TMV VRC.
That is, eEF1A interacts first with 126K through the M
domain and secondly recognizes and binds to PK in the 3V-
UTR of TMV genomic RNA to guide 126K close to TLS.
Thirdly, the downstream region of the M domain of 126K
binds to TLS. Fourthly, 183K carried by eEF1A binds to this
126K complex and forms a stabilized 126K/183K heterodimer
complex through the mediation of eEF1A. Finally, P domain
of 183K binds to 3V-terminal CCCA initiation site to start the
minus strand RNA synthesis. The order of the each step might
be different.
It is also possible that eEF1A is involved in the intracellular/
intercellular movement of TMV. TMV RdRp components have
been demonstrated to be involved in cell-to-cell movement
(Hirashima and Watanabe, 2001, 2003). Recent study revealed
that 126K modulates the size of VRCs and supports the
intracellular movement of VRCs along microfilaments (Liu et
al., 2005). Moreover, intercellular movement of TMVoccurs as
virus movement complexes (VMCs), which are similar or
identical to VRCs and include 126K and 183K (Kawakami et
al., 2004). Therefore, it is possible that eEF1A is included in
VMCs and participates in TMV cell-to-cell movement. Indeed,
the M domain, which is responsible for the interaction between
eEF1A and TMV RdRp, was required for cell-to-cell move-
ment of dRNA when it was co-inoculated with helper virus
(Knapp et al., 2005).
Thus, the interaction between eEF1A and TMV RdRp in
vivo hits upon various roles that eEF1A can play in TMV
multiplication. To elucidate the accurate role of it, muta-
tional analyses of TMV RdRp that disrupt the interactive
region should be required. It remains to be determined
whether the previously reported mutants of the M domain
(dos Reis Figueira et al., 2002; Merits et al., 1999;
Lewandowski and Dawson, 2000) interact with eEF1A. In
other approaches, the RNA silencing or the overexpression
of eEF1A in planta will reveal the effect of eEF1A on
TMV multiplication.
To understand the elaborate host–virus interactions, the
accumulation of the knowledge concerning the functions of
host proteins which participate in viral infection steps should
be necessary. The interaction between host EFs and viral
multiplication can be a model to study the molecular
mechanism of host–virus interaction since reports on the
interactions between EFs and the replication or translation of
several viral RNAs have been accumulating. Further eluci-
dation of EF functions in each RNA viral infection will
Y. Yamaji et al. / Virology 347 (2006) 100–108106reveal an aspect of the universality and specificity among
host–virus interactions.
Materials and methods
Cloning of a full-length eEF1A cDNA
A full-length cDNA of eEF1A was amplified by RT-PCR
from tobacco (N. tabacum cv. Xanthi) total RNA using primers,
EF1A-F (5V-TGC GAA TTC CAT ATG CCT GCC TTA GGT
TGT TG-3V) and EF1A-R (5V-TAC GCG TCG ACTACT CGA
GTG CAA CAC AGT AAG GCC A-3V), then cloned and
sequenced.
Antibody
Hexahistidin-tagged (His-) eEF1A was expressed in E. coli
using an expression vector pET30a (Novagen, Madison, WI,
USA) and purified as previously described (Watanabe et al.,
1999). Polyclonal antibody against eEF1A was raised in
rabbit using His-eEF1A as antigen and purified by Ampure
PA kit (Amersham, Piscataway, NJ, USA). Polyclonal
antibodies against the M domain, the H domain and the P
domain of TMV RdRp were previously described (Watanabe
et al., 1999). Antibodies against BSA and GST were obtained
from MP Biomedicals, Irvine, CA, USA and Amersham,
respectively.
GST pull-down assay for RNA
eEF1A cDNA was cloned into pGEX-4T-1 (Amersham) to
generate pGEX-eEF1A. pGEX-4T-1 or pGEX-eEF1A was
introduced into E. coli, and the expressed glutathione S-
transferase (GST) or GST-fused (GST-) eEF1A was purified
by manufacturer’s instruction. The 3V-UTR, 5V-UTR and MP
RNA fragments of TMV genomic RNAwere transcribed by T7
RNA polymerase from pTMV3V(+)-T7, pTMV5V(+)-T7 and
pET30K, respectively (Watanabe et al., 1999). pTMV3V(+)-T7,
pTMV5V(+)-T7 and pET30K include cDNA corresponding to
the nucleotide position 6147 to 6394, 1 to 149 and 5439 to
5708, respectively, of TMV genomic RNA downstream of the
T7 RNA promoter. Fifty microliters each of Glutathione
Sepharose 4B (Amersham) was incubated with 0.5 Ag of GST
or GST-eEF1A for 30 min and washed twice in phosphate-
buffered saline (PBS) containing 0.1% Triton X-100. The beads
were incubated with 1 Ag each of RNA fragment in RNA–
protein binding (RPB) buffer (phosphate buffer pH 7.0, 60 mM
KCl, 2 mM MgCl2, 1 mM dithiothreitol (DTT) and 5%
glycerol) for 30 min at 4 -C. Then, the beads were washed
once in RPB buffer and twice in PBS containing 0.1% Triton X-
100 and heated in SDS-polyacrylamide gel electrophoresis
(PAGE) sample buffer (50 mMTris–HCl pH 6.8, 100 mMDTT,
2% SDS, 10% glycerol and 0.1% bromophenol blue) at 95 -C
for elution. After centrifugation at 1000  g for 1 min, the
supernatant was separated by SDS-10% PAGE and subjected to
the detection by silver staining using 2D-silver stain-II (Daiichi
Pure Chemicals, Tokyo, Japan).Preparation of tobacco tissue extracts
Young leaves of tobacco plants (N. tabacum cv. Xanthi) were
inoculated with TMV-OM (Watanabe et al., 1999), and, 4 days
later, the inoculated leaves (2 g) were homogenized in liquid
nitrogen and then in 4 ml of buffer A (50 mM Tris–HCl, pH 7.5,
15 mMMgCl2, 120 mMKCl, 0.1% 2-mercaptoethanol and 20%
glycerol) containing protease inhibitor cocktail (Complete:
Roche, Mannheim, Germany, one tablet/50 ml). The homoge-
nate was filtered through Miracloth (Calbiochem, La Jolla, CA,
USA) and was centrifuged at 30,000  g for 30 min to generate
the supernatant fraction (S30) and the membrane-containing
pellet. After washing in buffer A, the pellet was suspended in 2
ml of buffer B (50 mM Tris–HCl pH8.2, 10 mM MgCl2, 120
mM KCl, 1 mM DTT and 1% TDC) containing protease
inhibitor cocktail, stirred gently for 1 h at 4 -C and centrifuged at
100,000  g for 30 min. Then, the supernatant was subjected to
the following assays as P30 fraction. Preparation of TMV
particles was as described (Watanabe et al., 1999).
Immunoblot analysis
Protein samples were subjected to SDS-PAGE and trans-
ferred to polyvinilidene difluoride (PVDF) membranes (Immo-
bilon P: Millipore, Bedford, MA, USA) and blocked in PBS
buffer containing 5% skim milk. Membranes were washed in
PBS buffer containing 0.05% Tween 20 and probed with
primary antibodies. Then, they were reacted with anti-rabbit
alkaline phosphatase conjugates (Biosource International,
Camarillo, CA, USA) as secondary antibody followed by a
colorimetric reaction using nitroblue tetrazolium and 5-bromo-
4-chloro-3-indolylphosphate-p-toluidine salts.
Immunoprecipitation
Immunoprecipitation was performed using Immunoprecipi-
tation Starter Pack (Amersham) according to the manufacturer’s
instructions. Ten percent volume of 10  RIPA buffer (50 mM
Tris–HCl, pH8.0, 150 mM NaCl, 1% Nonidet P-40, 0.5%
sodium deoxycholate, 0.1% SDS and 1 mM phenylmethane
sulfonyl fluoride (PMSF)), and 1 Ag of BSAwas added to P30 or
S30 fraction. Then, 30 Al of Protein A Sepharose Fast Flow resin
suspension (50% slurry in 1 RIPA buffer) was added, gently
mixed for 1 h at 4 -C, centrifuged at 1000 g for 1 min, and the
supernatant was saved. Subsequently, appropriate polyclonal
antibody was added to this supernatant and gently mixed for 1
h at 4 -C. For immunoprecipitation, 30 Al of resin suspension
(50% slurry) was added, gently mixed overnight at 4 -C,
centrifuged at 1000  g for 1 min, and the pellet was washed
three times by 1 RIPA buffer. The pellet was then suspended
in SDS-PAGE sample buffer, heated at 95 -C, centrifuged at
1000  g for 1 min, and the supernatant was used for zinc
staining by Zinc Stain and Destain Kit (Bio-Rad Laboratories,
Hercules, CA, USA) and for the immunoblot analysis. To
investigate the effect of RNase A on co-immunoprecipitation of
eEF1A and TMV RdRp, the following treatments were
performed prior to the immunoprecipitation. Elevated concen-
Y. Yamaji et al. / Virology 347 (2006) 100–108 107trations of RNase Awas added to P30 fractions and incubated at
37 -C for 30 min. Each 1 Al of these samples was used as a
template for RT-PCR analysis using primers (+)3V-UTR-F (AGA
GCT CTT CTG GTT TGG TTT GGA ACT CTG) and (+)3V-
UTR-R (CCC TAC CGG GGG TAA CGG GGG GAT TCG),
which amplify the cDNA fragment corresponding to 3V-UTR
(nucleotide position 6147 to 6389) of TMV genomic RNA.
GST pull-down assay for protein
The cDNA fragment of the M domain (nucleotide position 69
to 986), the I region (nucleotide position 966 to 2504), the H
domain (nucleotide position 2483 to 3416) or the P domain
(nucleotide position 3492 to 4919) was introduced into pGEX-
4T-1 and expressed in E. coli. The generated GST-M, -I, -H and -
P were purified as described above. Onemicrogram each of GST
or respective GST-fused proteins along with 1 Ag of BSA were
incubated with 50 Al of S30 or P30 fraction in the protein
interaction buffer (PBS buffer containing 1% Triton X, 0.5%
NP-40, 0.1% SDS and 1 mM PMSF) for 1 h at 4 -C. Fifty
microliters of Glutathione Sepharose 4B was added to each
reaction mixture and incubated overnight at 4 -C. The beads
were washed twice in PBS containing 1% Triton X-100 and
once in PBS and heated in SDS-PAGE sample buffer at 95 -C for
elution. After centrifugation at 1000  g for 1 min, the
supernatant was separated by SDS-12.5% PAGE and subjected
to immunoblotting.
Yeast two-hybrid assay
Yeast two-hybrid assay was performed using MATCH-
MAKER GAL4 Two-Hybrid System 3 (Clontech, Palo Alto,
CA, USA) as described (Shimizu et al., 2004). The cDNA
fragment of the M, I, H or P domain was inserted into pGBKT7
(pBD) to generate pBD-M, pBD-I, pBD-H or pBD-P,
respectively. Each of them or pBD was transformed into the
yeast AH109 with pGADT7 (pAD) or pAD fused with eEF1A
cDNA (pAD-eEF1A). As a positive control, yeast expressing
the C-terminal region of tobacco arginine decarboxylase fused
with AD (AD-ADC) and the H domain fused with BD (BD-H)
was used (Shimizu et al., 2004). The growth of each
transformed yeast was assayed on the selection medium
lacking leucine, tryptophan, adenine and histidine.
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